AVN 60.29 Increased By ▲ 0.14 (0.23%)
BOP 10.16 Increased By ▲ 0.05 (0.49%)
CHCC 129.15 Decreased By ▼ -0.91 (-0.7%)
DCL 9.35 Decreased By ▼ -0.21 (-2.2%)
DGKC 105.67 Increased By ▲ 0.13 (0.12%)
EFERT 68.20 Increased By ▲ 0.50 (0.74%)
EPCL 30.52 Decreased By ▼ -0.13 (-0.42%)
FCCL 21.28 Decreased By ▼ -0.04 (-0.19%)
FFL 13.14 Decreased By ▼ -0.15 (-1.13%)
HASCOL 15.83 Increased By ▲ 1.46 (10.16%)
HBL 128.00 Increased By ▲ 2.65 (2.11%)
HUBC 86.74 Increased By ▲ 6.59 (8.22%)
HUMNL 9.37 Increased By ▲ 0.57 (6.48%)
JSCL 16.98 Decreased By ▼ -0.22 (-1.28%)
KAPCO 27.78 Increased By ▲ 2.38 (9.37%)
KEL 3.85 Increased By ▲ 0.09 (2.39%)
LOTCHEM 12.90 Decreased By ▼ -0.05 (-0.39%)
MLCF 35.62 Increased By ▲ 0.17 (0.48%)
OGDC 114.71 Increased By ▲ 2.06 (1.83%)
PAEL 35.15 Increased By ▲ 0.50 (1.44%)
PIBTL 12.15 Increased By ▲ 0.26 (2.19%)
PIOC 87.90 Increased By ▲ 0.79 (0.91%)
POWER 8.90 Decreased By ▼ -0.46 (-4.91%)
PPL 101.76 Increased By ▲ 2.26 (2.27%)
PSO 187.60 Increased By ▲ 4.90 (2.68%)
SNGP 57.10 Increased By ▲ 2.10 (3.82%)
STPL 11.82 Decreased By ▼ -0.08 (-0.67%)
TRG 49.02 Decreased By ▼ -1.28 (-2.54%)
UNITY 13.24 Decreased By ▼ -0.21 (-1.56%)
WTL 1.32 Decreased By ▼ -0.04 (-2.94%)
BR100 4,230 Increased By ▲ 84 (2.02%)
BR30 21,819 Increased By ▲ 626 (2.96%)
KSE100 40,559 Increased By ▲ 644 (1.61%)
KSE30 17,607 Increased By ▲ 345 (2%)
COVID-19 TOTAL DAILY
CASES 285,191 531
DEATHS 6,112 15
Sindh 124,127 Cases
Punjab 94,586 Cases
Balochistan 11,921 Cases
Islamabad 15,281 Cases
KP 34,755 Cases

Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive Officer, Elon Musk, tweeted on Wednesday.

CureVac, an unlisted German company, has said it is developing portable, automated mRNA production units that it calls printers and which Musk described as "RNA microfactories".

They are being designed to be shipped to remote locations, where they can churn out its vaccine candidate and other mRNA-based therapies depending on the recipe fed into the machine.

But for the immediate pandemic use - should its vaccine candidate win market approval - it has production sites with regulatory approval in Germany with a capacity to produce hundreds of millions of doses.

The company, based in Tuebingen and backed by the Bill & Melinda Gates Foundation, is a pioneer of the so-called messenger RNA approach, which is also pursued by BioNTech and its partner Pfizer as well as Moderna .

RNA molecules are single-stranded versions of the DNA double-helix. Thanks to their recurring molecular pattern, they can be produced in a relatively simple biochemical process that do not require genetically modified living cells, which are needed to produce most other biotech drugs.

CureVac is also building a new stationary site that could increase its output tenfold to billions of doses.

The "microfactories" would be built at Tesla Grohmann Automation in Germany, Musk said in a Twitter thread late on Wednesday night.

Tesla acquired the company that develops automated manufacturing systems for batteries and fuel cells in 2016 to expand its production.

CureVac has been working with Tesla Grohmann to develop the mobile printer technology, a person familiar with CureVac said.

Musk did not elaborate on his plans. Tesla and CureVac were not immediately available to comment.

Musk, who is known to make impromptu announcements on Twitter, had in March said that Tesla has extra FDA-approved ventilators that can be shipped free of cost to hospitals within regions where the electric-car maker delivers.